Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
Analyse IA de SOLITON INC
Cliquez sur l’une des analyses ci-dessous pour obtenir des informations instantanées de l’IA via finAgent
Dernières analyses d’IA sur SOLITON INC
Aucun fil IA disponible pour cette entreprise pour le moment.